To improve cardiovascular health and reduce the CVD burden in the Asia-Pacific – for patients, societies and economies.
We will do this by:
Partnering patients and health systems across the care continuum – from early detection, prevention, treatment to step-down care.
Breaking down silos between patients, policymakers, and professionals.
Advocating investment in CVD action for healthy people across all ages.
The Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) was formally established in 1982 with originally just 5 member societies. Today in 2023, after more than forty years of growth and development, the APFCB is a massive regional federation whose member countries contain approximately half the world’s population; currently there are 18 Full Members, 5 Affiliate Members and 22 Corporate Members.
Apart from the size, a feature of the APFCB is the diverse range of laboratory practices. As a Federation committed to raising the quality, equity and sustainability of Laboratory Medicine region throughout our region, this enables a unique position for drawing on the expertise of the more developed societies to assist the less developed.
The APFCB also has a good history of collaboration with other international federations, particularly a long-standing partnership and vital support from the IFCC. In addition, the APFCB has on-going MoUs with the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) and the American Association for Clinical Chemistry (AACC).
The Global Alliance for Patient Access is an international platform for healthcare providers and patient advocates to inform policy dialogue about patient-centered care.
Global Heart Hub is the first global non-profit organisation established to provide a voice for those affected by cardiovascular disease. It is an alliance of heart patient organisations aiming to create a unified global voice for those living with or affected by heart disease.
Heart Support Australia is the peak national body providing support to Australians affected by heart disease through peer support. Established in 1989, our mission is to facilitate the transition from hospital to home and provide ongoing support for heart disease patients in Australia. Our goal at Heart Support Australia is to stop secondary cardiac events and improve the lives of those living with heart disease in Australia. Heart Support Australia plays an active role with our partners in advocating for our consumers to Government and other stakeholders on a range of issues that affect those living with heart disease.
Universiti Teknologi MARA (UiTM) Faculty of Medicine was officially established in November 2002 and the first intake of medical students were admitted in June 2003. Currently about 250 students are admitted each year. The Sungai Buloh campus was completed in 2012 and all the administrative and academic staff moved from Shah Alam to Sungai Buloh. Teaching and classes of the pre-clinical as well as the clinical years then commenced at Sungai Buloh campus. Apart from the teaching facilities, the faculty also developed its own clinical services. In 2016 it was formalized into UiTM Medical Specialist Centre (PPUiTM), which offer services in cardiology, respiratory, gastroenterology, general medicine, general surgery, orthopaedics, rehabilitation medicine, ophthalmology, obstetrics and gynaecology, paediatrics, dermatology and primary care services. The UiTM teaching hospital, Hospital Al-Sultan Abdullah UiTM, is now in full operation in Puncak Alam, Selangor.
ACCESS Health International is a global health nonprofit advisory and implementation partner. Founded in 2007, we have in-country consultants in ten markets across Asia and offices in Dubai, Hyderabad, New Delhi, and Singapore. We specialize in health policy, health systems financing, and care integration. We have extensive networks and develop meaningful relationships with public sector, industry, multilaterals, and civil society alike.